Syed Nuruddin

About

Syed Nuruddin is an Associate Professor-II at the University of Oslo. His research focuses on preclinical evaluations in cancer imaging and the discovery of novel receptor antagonists in neuropharmacology. Notable recent publications include a study on the use of [18F]cabozantinib as a PET imaging agent in prostate cancer models and the identification of a brain-penetrating gonadotropin-releasing hormone receptor antagonist. He is actively contributing to the advancement of medical research in Norway.